PARNAX LAB
|
PARNAX LAB Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 8.37 | 7.50 | 8.40 | -0.43 | -3.43 |
| CEPS(Rs) | 14.44 | 13.20 | 14.39 | 5.64 | 1.81 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 62.32 | 54.11 | 47.24 | 38.26 | 38.56 |
| Tax Rate(%) | 20.12 | 29.70 | 32.66 | -332.77 | -48.23 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.48 | 13.72 | 14.13 | 11.04 | 6.74 |
| EBIT Margin(%) | 9.22 | 10.28 | 10.73 | 5.55 | 2.76 |
| Pre Tax Margin(%) | 6.39 | 7.33 | 7.52 | -0.09 | -2.06 |
| PAT Margin (%) | 5.10 | 5.15 | 5.07 | -0.40 | -3.06 |
| Cash Profit Margin (%) | 8.79 | 9.05 | 8.66 | 5.33 | 1.62 |
| Performance Ratios | |||||
| ROA(%) | 5.77 | 5.78 | 6.36 | -0.34 | -2.89 |
| ROE(%) | 14.39 | 15.91 | 20.93 | -1.11 | -8.51 |
| ROCE(%) | 13.61 | 15.20 | 17.34 | 5.83 | 3.27 |
| Asset Turnover(x) | 1.13 | 1.12 | 1.26 | 0.84 | 0.94 |
| Sales/Fixed Asset(x) | 1.61 | 1.63 | 1.85 | 1.18 | 1.42 |
| Working Capital/Sales(x) | -18.83 | -29.31 | -16.38 | -4.77 | -9.00 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.62 | 0.61 | 0.54 | 0.84 | 0.70 |
| Receivable days | 58.46 | 71.83 | 61.33 | 80.64 | 80.93 |
| Inventory Days | 49.92 | 45.31 | 34.39 | 44.46 | 37.57 |
| Payable days | 65.58 | 75.70 | 57.63 | 74.68 | 73.02 |
| Valuation Parameters | |||||
| PER(x) | 15.48 | 6.94 | 15.68 | - | - |
| PCE(x) | 8.97 | 3.94 | 9.15 | 3.46 | 6.68 |
| Price/Book(x) | 2.08 | 0.96 | 2.79 | 0.51 | 0.31 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.15 | 0.64 | 1.16 | 0.79 | 0.62 |
| EV/Core EBITDA(x) | 8.95 | 4.54 | 8.09 | 6.98 | 8.39 |
| EV/EBIT(x) | 12.53 | 6.26 | 10.80 | 14.20 | 22.58 |
| EV/CE(x) | 1.53 | 0.95 | 1.23 | 0.67 | 0.56 |
| M Cap / Sales | 0.79 | 0.36 | 0.79 | 0.18 | 0.11 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 12.59 | 2.81 | 81.03 | -5.51 | -12.38 |
| Core EBITDA Growth(%) | 2.53 | 1.71 | 129.99 | 43.18 | -42.47 |
| EBIT Growth(%) | 0.96 | -1.51 | 250.08 | 89.69 | -69.03 |
| PAT Growth(%) | 11.49 | 4.54 | 2,378.51 | 87.57 | -188.22 |
| EPS Growth(%) | 11.50 | -10.66 | 2,062.37 | 87.51 | -188.34 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.99 | 0.82 | 1.41 | 1.71 | 1.54 |
| Current Ratio(x) | 0.88 | 0.91 | 0.88 | 0.65 | 0.80 |
| Quick Ratio(x) | 0.51 | 0.57 | 0.63 | 0.45 | 0.59 |
| Interest Cover(x) | 3.25 | 3.48 | 3.34 | 0.98 | 0.57 |
| Total Debt/Mcap(x) | 0.48 | 0.85 | 0.51 | 3.35 | 4.90 |
Compare Financial Ratios of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹102.4 Cr | -3.3% | -16.1% | -23.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,771.0 Cr | -3.4% | -0.2% | 18.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,175.0 Cr | -2.3% | 3.4% | 55.5% | Stock Analytics | |
| CIPLA | ₹120,076.0 Cr | -2.6% | -0.6% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹107,727.0 Cr | -2.3% | -2.1% | 20.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,853.9 Cr | -2.9% | -0.2% | -8.7% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | -3.3% |
-16.1% |
-23.7% |
| SENSEX | 0.1% |
4.9% |
7.7% |
You may also like the below Video Courses
